# Quadripolar Leads for the Management of Heart Failure Patients in the Middle East

Study · id `cardio:ct-nct02195843` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02195843](<https://clinicaltrials.gov/study/NCT02195843>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02195843

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 389 participants.

## Technical summary

Registry record NCT02195843. Randomized; no masking. Start 2014-08 (registry gives no type); primary completion 2016-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking
- Phase: Phase 4
- Enrolled: 389 participants (planned count; ClinicalTrials.gov record NCT02195843, source copy `cardio:ctgov-nct02195843-2014-07-21`, retrieved 2026-10-26)
- Start date: 2014-08 (registry gives no type) (ClinicalTrials.gov record NCT02195843, source copy `cardio:ctgov-nct02195843-2014-07-21`, retrieved 2026-10-26)
- Primary completion: 2016-08 (anticipated) (ClinicalTrials.gov record NCT02195843, source copy `cardio:ctgov-nct02195843-2014-07-21`, retrieved 2026-10-26)
- Completion: 2016-08 (anticipated) (ClinicalTrials.gov record NCT02195843, source copy `cardio:ctgov-nct02195843-2014-07-21`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02195843-2014-07-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Quadripolar Leads for the Management of Heart Failure Patients in the Middle East
- Acronym: QUADRA-ME
- Condition: Heart Failure
- Intervention (Other): Electrical optimization by RVLV Conduction Time with VectSelect
- Intervention (Other): Anatomical optimization of device and leads
- Intervention (Device): Implanted device and lead (Cardiac Resynchronization Therapy Defibrillator (CRT-D) device and SJM Quadripolar lead system)
- Lead sponsor: King Abdullah International Medical Research Center
- Lead sponsor class: OTHER
- Collaborator: Abbott Medical Devices
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: King Abdullah International Medical Research Center (`cardio:org-king-abdullah-international-medical-research-center`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)

## Provenance

Content hash: 8a80dd2e4e7235e5410b6aadf64dec8c293a2fb715d699b9c770f35a7c90eb7c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
